The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Treatment of Neurohypophyseal Diabetes Insipidus
Abstract
CONTEXT: In recent years, there have been several improvements in the treatment of neurohypophyseal diabetes insipidus (DI). They include new formulations of the vasopressin analog, desmopressin; a better understanding of the effect of fluid intake on dosing; and more information about treatments of infants, children, and pregnant women who present special challenges. This review aims to summarize past and current information relative to the safety and efficacy of treatments for the types of DI caused by a primary deficiency of vasopressin. EVIDENCE ACQUISITION: The review is based on publications identified primarily by a PubMed search of the international literature without limitations of date. EVIDENCE SYNTHESIS: In acute settings where fluid intake is determined by factors other than thirst, desmopressin should be given iv in doses that have a short duration of action and can be adjusted quickly in accordance with changes in hydration as indicated by plasma sodium. In ambulatory patients, the oral formulations (tablet or melt) are preferred for their convenience. If fluid intake is regulated normally by the thirst mechanism, the tablets or melt can be taken safely 1 to 3 times a day in doses sufficient to completely eliminate the polyuria. However, if fluid intake consistently exceeds replacement needs as evidenced by the development of hyponatremia, the dose should be reduced to allow higher than normal rates of urine output or intermittent breakthrough diuresis. This regimen is often indicated in infants or children because their rate of fluid intake tends to be greater than in adults. In all cases, the appropriate dose should be determined by titration, owing to considerable interindividual differences in bioavailability and antidiuretic effect. CONCLUSIONS: Desmopressin can provide effective and safe therapy for all patients with neurohypophyseal or gestational DI if given in doses and by a route that takes into account the determinants of fluid intake.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As GH suppresses the conversion of cortisone to cortisol, patients receiving GC replacement may require higher doses once GH is initiated, and those with low adrenal reserve may be rendered hypoadrenal by the GH therapy (183,187).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [183]
In the citing paper
“Many features of hypopituitarism, such as visceral obesity, insulin resistance, osteoporosis, and increased vascular mortality are reminiscent of Cushing's syndrome (183,184).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [183]
In the citing paper
“Lower doses of HC might be needed in women with hypopituitarism (compared with primary AI) who are not treated with GC replacement (28,110,112,183,184).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [183]
In the citing paper
“The oral desmopressin has low bioavailability but good antidiuretic effect [3]”
From Diabetes Insipidus after Traumatic Brain Injury (2015) · cites this paper as [3]
Citations
Cites
Aquaporins in the Kidney: From Molecules to Medicine
Nielsen, S., Frøkiær, J., Marples, D., Kwon, T.-H., Agre, P., & Knepper, M. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00024.2001 · Cited by 1,251 · cited 1×
“Both produce antidiuresis by stimulating V2 receptors on the principal cells of the kidney (13).”
Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus
Rosenthal, W., Seibold, A., Antaramian, A., Lonergan, M., Arthus, M.-F., Hendy, G. N., Birnbaumer, M., & Bichet, D. G. (1992) · Nature · doi:10.1038/359233a0 · Cited by 333 · cited 1×
“This type is referred to as nephrogenic DI and can also be acquired or genetic (4, 5).”
MANNING, M., STOEV, S., CHINI, B., DURROUX, T., MOUILLAC, B., & GUILLON, G. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00437-8 · Cited by 296 · cited 1×
“Desmopressin does not have this effect because it is relatively inactive at V1 receptors (14).”
Zerbe, R. L., & Robertson, G. L. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112243052601 · Cited by 268 · cited 1×
“This finding is consistent with a previous suggestion that the concentrating capacity of the human kidney decreases in the absence of vasopressin and seems to require more than 8 hours of continued stimulation to fully recover (24).”
Self-citationHyponatremia Associated with Carbamazepine and Oxcarbazepine Therapy: A Review
Van Amelsvoort, T., Bakshi, R., Devaux, C. B., & Schwabe, S. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb02930.x · Cited by 250 · cited 1×
“Use of carbamazepine to treat neurological disorders has also been implicated in the development of hyponatremia with inappropriate antidiuresis (50).”
Abnormalities of thirst regulation
Robertson, G. L. (1984) · Kidney International · doi:10.1038/ki.1984.39 · Cited by 193 · cited 4×
“Dipsogenic polydipsia Tubeculous meningitis Neurosarcoidosis Head trauma Idiopathic Causes of hypodipsia and vasopressin deficiency resulting from destruction of osmoreceptors (86) Tumors Craniopharyngioma Pinealoma Meningioma Metastatic Granulomas Histiocytosis Sarcoidosis Vascular Occlusion of anterior communicating…”
InfluentialSelf-citationOsmoregulation, the secretion of arginine vasopressin and its metabolism during pregnancy
Lindheimer, M. D., & Davison, J. M. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1320133 · Cited by 179
EFFECT OF A SYNTHETIC ANALOGUE OF VASOPRESSIN IN ANIMALS AND IN PATIENTS WITH DIABETES INSIPIDUS
Vávra, I., Machová, A., Holecek, V., Cort, J. H., Zaoral, M., & Sorm, F. (1968) · The Lancet · doi:10.1016/s0140-6736(68)90904-5 · Cited by 179 · cited 1×
“the first clinical trial over 40 years ago (16).”
Familial forms of diabetes insipidus: clinical and molecular characteristics
Babey, M., Kopp, P., & Robertson, G. L. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.100 · Cited by 172 · cited 5×
“For long-term management, however, the only practical way to reduce the polyuria, thirst, and polydipsia is to reduce sodium intake and give a thiazide diuretic, amiloride, or prostaglandin synthetase inhibitors (2, 4).”
InfluentialSelf-citationDesmopressin 30 Years in Clinical Use: A Safety Review
Vande Walle, J., Stockner, M., Raes, A., & Norgaard, J. (2007) · Current Drug Safety · doi:10.2174/157488607781668891 · Cited by 172
Self-citation
Cited by
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Christ-Crain, M., Bichet, D. G., Fenske, W. K., Goldman, M. B., Rittig, S., Verbalis, J. G., & Verkman, A. S. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0103-2 · Cited by 256
Diagnosis and Management of Central Diabetes Insipidus in Adults
Tomkins, M., Lawless, S., Martin-Grace, J., Sherlock, M., & Thompson, C. J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac381 · Cited by 159
Diabetes insipidus: Differential diagnosis and management
Robertson, G. L. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.02.007 · Cited by 134
Self-citationDiabetes Insipidus after Traumatic Brain Injury
Capatina, C., Paluzzi, A., Mitchell, R., & Karavitaki, N. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4071448 · Cited by 120
Metadata
- Authors
- Oiso, Y., Robertson, G. L., Nørgaard, J. P., & Juul, K. V.
- Affiliations
- Ghent University (BE)
- Northwestern University (US)
- Ferring Pharmaceuticals (Denmark) (DK)
- Corresponding author
- Juul, Kristian Vinter
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-10
- Volume
- 98
- Issue
- 10
- Pages
- 3958-3967
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2154417986
- Cited by
- 101
- References
- 84
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 4 · 2023: 6 · 2022: 8 · 2021: 7 · 2020: 9 · 2019: 12 · 2018: 6 · 2017: 10 · 2016: 7 · 2015: 7 · 2014: 13 · 2013: 1
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Funders
- Universiteit Gent
- Faculty of Medicine and Health, University of Sydney
- Topics
- Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- desmopressin, vasopressin analogue, fluid intake, hyponatremia, polyuria, dose titration, infants, children, pregnancy, gestational diabetes insipidus, plasma sodium
- MeSH terms
- Deamino Arginine Vasopressin, Humans, Polyuria, Treatment Outcome, Diabetes Insipidus, Neurogenic, Antidiuretic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Neurohypophyseal Diabetes Insipidus. https://app.cochat.ai/papers/10.1210/jc.2013-2326
- The paper
- Oiso, Y., Robertson, G. L., Nørgaard, J. P., & Juul, K. V. (2013). Treatment of Neurohypophyseal Diabetes Insipidus. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2013-2326
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.